Can clonidine, enoximone, and enalaprilat help to protect the myocardium against ischaemia in cardiac surgery?

Heart

Volumn 76, Issue 3, 1996, Pages 207-213

  Boldt, Joachim ^a,b   Rothe, Gabriele ^a   Schindler, Ehrenfied ^a   Döll, Carsten ^a   Görlach, Gerold ^a   Hempelmann, Gunter ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b KLINIKUM LUDWIGSHAFEN   (Germany)

Author keywords

Ischaemic markers; Myocardial preservation; Myocardial tissue damage; Surgery

Indexed keywords

CLONIDINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; ENOXIMONE; PHOSPHODIESTERASE INHIBITOR;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; DRUG EFFICACY; HEART MUSCLE ISCHEMIA; HEMODYNAMICS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REPERFUSION INJURY;

EID: 0029740894     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.76.3.207     Document Type: Article

References (39)

1. Slogoff S, Keats AS. Further observations on perioperative myocardial ischemia. Anesthesiology 1986;65:539-42.
2. Balderman SC, Bhayana JN, Steinbach JJ. Perioperative myocardial infarction: a diagnostic dilemma. Ann Thorac Surg 1980;30:370-7.
3. Haagensen R, Steen PA. Perioperative moycardial infarction. Br J Anaesth 1988;61:24-37.
4. Mair PM, Mair J, Seibt I, Furtwaingler W, Waldenberger F, Puschendorf B, et al. Cardiac troponin T: a new marker of myocardial tissue damage in bypass surgery. J Cardiothorac Vasc Surg 1993;7:674-8.
5. Katus HA, Schoeppenthau M, Tanzeem A, Bauer HG, Saggau W, Diederich KW, et al. Noninvasive assessment of perioperative myocardial cell damage by circulating cardiac troponin T. Br Heart J 1991;65:259-64.
6. Mair J, Artner DE, Lechleitner P, Smist J, Wagner I, Dienstl F, et al. Cardiac troponin T in diagnosis of acute myocardial infarction. Clin Chcm 1991;37:845-52.
7. Katus HA, looser S, Hallmeier K, Remppis A, Scheffolf T, Borgya A, et al. Development and in vitro characterization of a new immunoassay of cardiac troponin T. Clin Chem 1992;38:386-93.
8. Adams JE, Abendschein DR, Jaffe AS. Biochemical markers of myocardial injury: is MB creatine kinase the choice of the 1990s? Circulation 1993;88:750-63.
9. Gerhardt W, Katus HA, Ravkilde J, Hammm C, Jorgensen PJ, Peheim E, et al. S-troponin T in suspected ischemic myocardial injury compared with mass and catalytic concentrations of S-creatinine kinase isoenzyme MB. Clin Chem 1991;37:1405-11.
10. Mair J, Puschendorf B, Smidt J, Lechleitner P, Dients F, Noll F, et al. Early release of glycogen phosphorylase in patients with unstable angina and transient ST-T alterations. Br Heart J 1994;72:125-7.
11. Entman ML, Bornet EP, Vanwickle WB, Goldstein MA, Schwartz A. Association of glycogenolysis with cardiac sarcoplasmatic reticulum: effects of glycogen depletion, deoxycholate solubilization and cardiac ischemia: evidence for a phosphorylase kinase membrane complex. J Mol Cell Cardiol 1977;9:515-28.
12. Michael LH, Hunt JR, Weilbacher D, Perryman MB, Roberts R, Lewis RM. Creatine kinase and phosphorylase in cardiac lymph: coronary occlusion and reperfusion. Am J Physiol 1995;248:H350-9.
13. Rabitzsch G, Mair J, Lechleitner P, Noll F, Hoffmann U, Krause EG, et al. Isoenzyme BB of glycogen phosphorylase b and myocardial infarction. Lancet 1993;241: 1032-3.
14. Davies ME, Jones CJH, Feneck RO, Walesby RK. The effects of intravenous nitroglycerin and isosorbide dinitrate on hemodynamics and myocardial metabolism. J Cardiothorac Vase Anesth 1989;3:712-9.
15. Seitelberger R, Zwölfer W, Binder T, Huber S, Peschl F, Spatt J, et al. Infusion of nifedipine after coronary bypass grafting decreases the incidence of early postoperative myocardial ischemia. Ann Thorac Surg 1990;49:61-8.
16. Bolling SF, Groh MA, Mattson AM, Gringae RA, Gallagher K. Acadesine (AICA-Riboside) improves postischemic cardiac recovery. Ann Thorac Surg 1992;54: 93-9.
17. Dorman BH, Zucker JR, Verrier ED, Gartman DM, Slachman FN. Clonidine improves perioperative myocardial ischemia, reduces anesthetic requirement, and alters hemodynamic parameters in patients undergoing coronary artery bypass surgery. J Cardiothorac Vasc Anesth 1992;6:344-59.
18. Thormann J, Kremer P, Mitrovic V: Effects of enoximone in coronary artery disease: increased pump function, improved ventricular wall motion and abolition of pacing induced myocardial ischemia. J Appl Cardiol 1989;4: 152-67.
19. Hock CE, Ribeiro LG, Lefer AM. Preservation of ischemic myocardium by a new converting enzyme inhibitor, enalaprilic acid, in acute myocardial infarction. Am Heart J 1985;109:222-8.
20. Smith RC, Leung JM, Mangano DT, the SPJ Research Group. Postoperative myocardial ischemia in patients undergoing coronary artery bypass graft surgery. Anesthesiology 1991;74:464-73.
21. Hofmann U, Rabitzsch, Lüster K, Handschack W, Noll F, Krause EG. Immunenzymometric assay for the heart specific glycogen phosphorylase BB in humans using monoclonal antibodies. Biomed Biochem Acta 1989;48: 132-6.
22. Rabitzsch G, Noll F, Hofmann U, Krause EG, Armbruster FP. Basal concentration of the isoenzyme BB of the glycogen phosphorylase in human blood. Clin Chim Acta 1993;214:109-11.
23. Feindt P, Volkmer I, Seyffert UT, Haack H. The role of protein C as an inhibitor of blood clotting during extracorporeal circulation. Thorac Cardiovasc Surgeon 1991;39: 338-43.
24. Heusch G, Schipke J, Thamer V. Clonidine prevents the sympathetic initiation and aggravation of poststenotic myocardial ischemia. J Cardiovasc Pharmacol 1985;7: 1176-82.
25. Lee TH, Goldman L. Serum enzyme assays in the diagnosis of acute myocardial infarction. Ann Int Med 1987;105: 221-33.
26. Schlepper M, Thorman J, Mitrovic V. Cardiovascular effects of forskolin and phosphodiesterase-III inhibitors. Bas Res Cardiol 1989;84(suppl 1):197-212.
27. Mitrovic V, Thorman J, Neuzner J, Bahavar H, Volz M, Dieterich HA, et al. Hemodynamic, antiischemic, and neurohumoral effects of enoximone in patients with coronary artery disease. Am Heart J 1989;117:106-11.
28. Colson P. Angiotensin-converting enzyme inhibitors in cardiovascular anesthesia. J Cardiothorac Vase Anesth 1993; 7:734-42.
29. Murphy JD, Vaughan RS, Rosen M. Intravenous enalaprilat and autonomic reflexes. Anaesthesia 1989;44:816-21.
30. Thürmann P, Rietbrock N. Current concepts: converting enzyme inhibitors in coronary artery disease. Clin Invest 1992;70:70-6.
31. Chatterjee K, Marco TD. Systemic and coronary hemodynamics and pharmacokinetics of enalapril and enalaprilat in congestive heart failure. Drugs 1990;39(suppl 4): 29-40.
32. Dzau VJ. Circulating versus local renin-angiotensin in cardiovascular homeostasis. Circulation 1988;77(suppl I): 4-13.
33. Grover GJ, Sleph Pb, Dzoncyk S, Wang P, Fung W, Tobias D, et al. Effect of different angiotensin-converting enzyme (ACE) inhibitors on ischemic related rat hearts: relationship between cardiac ACE inhibition and cardioprotection. J Pharmacol Exp Ther 1991;257:919-29.
34. Kulka PJ, Tryba M, Zenz M. Dose-response effects of intravenous clonidine on stress response during induction of anesthesia in coronary artery bypass graft patients. Anesth Analg 1995;80:263-8.
35. Weber KT, Janicki JS, Jain MC. Enoximone (MDL 17,043), a phosphodiesterase inhibitor, in the treatment of advanced, unstable chronic heart failure. J Heart Transplant 1986;5:105-12.
36. Sigurdsson A, Held P, Andersson G, Swedberg K. Enalaprilat in acute myocardial infarction, tolerability and effects on the renin-angiotensin system. Int J Cardiol 1991;33:115-24.
37. DiPette DJ, Ferraro JC, Evans RR. Enalaprilat, an intravenous angiotensin-converting enzyme inhibitor, in hypertensive crisis. Clin Pharmacol Ther 1995;38: 199-204.
38. Thompson IR. Con: Intraoperative myocardial ischemia is not benign. J Cardiothorac Vasc Anesth 1994;8:593-5.
39. Mangano DT, Hollenberg M, Fegert G. Perioperative myocardial ischemia in patients undergoing non-cardiac surgery - I. Incidence and severity during the 4 day perioperative period. Am J Coll Cardiol 1991;17:843-50.